Implementation of reforms in Canada that will lower drug prices but which pharmaceutical industry representatives claim will deter R&D investment and impact access to new medicines have been put on hold just two days before they were due to come into force. In light of the COVID-19 pandemic, the drug pricing reforms will now be implemented on 1 January 2022, instead of 1 July 2021, says Health Canada.
“In consideration of the impact of the third wave of the COVID-19 pandemic and the ongoing efforts related to the...